We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 573

Eleventh Circuit affirms dismissal of relator’s complaint under amended public disclosure bar

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • March 3 2015

In United States of America ex rel. Marc Osheroff v. Humana, Inc. et al., No. 13-15278 (11th Cir., Jan. 16, 2015), the Eleventh Circuit affirmed

Tapping into the big value of health care Big Data top legal and regulatory considerations on the path to monetization

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • March 2 2015

The proliferation of electronic medical records and Mobile devices, enhanced computing platforms and Infrastructure, new data sharing and mining

State attorneys general return to health care reform in U.S. Supreme Court

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • March 2 2015

On Wednesday, the U.S. Supreme Court will hear arguments in what is being teed up to be “Round 2” on the Affordable Care Act (ACA). In the case King

CMS extends eligible professional attestation deadline for 2014 Medicare EHR Incentive Program

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • February 27 2015

The Centers for Medicare and Medicaid Services (CMS) has extended the deadline for eligible professionals to attest to meaningful use for the

Do you really know your China telemedicine partners? China anti-corruption effort focuses on major medical institutions

  • Foley & Lardner LLP
  • -
  • China, USA
  • -
  • February 24 2015

As U.S.-based healthcare providers look to China for new telemedicine opportunities, it is important to know your China partners before signing the

Roadmap to prison: lessons learned from the criminal prosecution of Alpha ambulance’s leaders

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • February 23 2015

No one running an ambulance company ever planned to go to prison for doing his or her job. But that is a real possibility if the government knocks on

Direct-to-consumer genetic test authorized by FDA

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • February 23 2015

23andMe is not a traditional diagnostics company. Rather than seeking to directly sell its services to health care professionals, 23andMe went

Patenting stem cells in view of the USPTO’s new Interim Guidance

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • February 16 2015

Late last year, the USPTO issued its modified and revised 2014 Interim Guidance on Patent Subject Matter Eligibility (Interim Guidance) to assist

What does President Obama's $215 million "Precision Medicine Initiative" mean for genetic privacy?

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • February 12 2015

We have all heard about the burgeoning opportunities tied to the development of precision medicine (also called “personalized medicine”), which

Cooperative Hospital Service Organizations: a hospital joint venture option

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • February 9 2015

Cooperative Hospital Service Organizations (CHSOs) are organizations that are available for hospitals considering certain types of joint ventures